Review article: Ulcerative colitis, Smoking and nicotine therapy

Alimentary Pharmacology and Therapeutics

Volumn 36, Issue 11-12, 2012, Pages 997-1008

  Lunney, P C ^a   Leong, R W L ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; ENEMA; HEME OXYGENASE 1; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MESALAZINE; NICOTINE; NICOTINE ENEMA; NICOTINE GUM; NICOTINE PATCH; NICOTINE TARTRATE; NITRIC OXIDE SYNTHASE; PLACEBO; PREDNISOLONE; PREDNISONE; PROSTAGLANDIN E2; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; NICOTINIC AGENT;

ACUTE PANCREATITIS; APOPTOSIS; CELLULAR IMMUNITY; COLON RESECTION; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; ENTERITIS; ENZYME ACTIVITY; HEADACHE; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNITY; ILEITIS; MAINTENANCE DRUG DOSE; MAXIMUM TOLERATED DOSE; NAUSEA; NICOTINE REPLACEMENT THERAPY; NONHUMAN; PRIORITY JOURNAL; PRURITUS; RELAPSE; REMISSION; REVIEW; RISK FACTOR; SCLEROSING CHOLANGITIS; SIGMOIDOSCOPY; SLEEP DISORDER; SMOKING; TH1 CELL; ULCERATIVE COLITIS; CLINICAL TRIAL (TOPIC);

CLINICAL TRIALS AS TOPIC; COLITIS, ULCERATIVE; HUMANS; NICOTINE; NICOTINIC AGONISTS; SMOKING;

EID: 84875885230     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12086     Document Type: Review

References (87)

1. Cosnes J. What is the link between the use of tobacco and IBD? Inflamm Bowel Dis 2008;14:S14-5.
2. McGilligan VE, Wallace J M W, Heavey PM, et al. Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis. Inflamm Bowel Dis 2007;13:108-15. (Pubitemid 46080016)
3. Nikfar S, Ehteshami-Ashar S, Rahimi R, et al. Systematic review and metaanalysis of the efficacy and tolerability of nicotine preparations in active ulcerative colitis. Clin Ther 2010;32:2304-1315.
4. Aldhous MC, Drummond HE, Anderson N, et al. Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitis. Am J Gastroenterol 2007;102:589-97. (Pubitemid 46328159)
5. Bastida G, Beltrán B. Ulcerative colitis in smokers, non-smokers and exsmokers. World J Gastroenterol 2011;17:2740-7.
6. Birrenbach T, Böcker U. Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis 2004;10:848-59. (Pubitemid 39549299)
7. Benoni C, Nilsson A. Smoking habits in patients with inflammatory bowel disease. A case-control study. Scand J Gastroenterol 1987;22:1130-6. (Pubitemid 17157010)
8. Benoni C, Nilsson A. Smoking habits in patients with inflammatory bowel disease. Scand J Gastroenterol 1984;19:824-30. (Pubitemid 14027535)
9. Boyko EJ, Koepsell TD, Perera DR, et al. Risk of ulcerative colitis among former and current cigarette smokers. N Engl J Med 1987;316:707-10. (Pubitemid 17036475)
10. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989;34:1841-54. (Pubitemid 20018648)
11. Fraga XF, Vergara M, Medina C, et al. Effects of smoking on the presentation and clinical course of inflammatory bowel disease. Eur J Gastroenterol Hepatol 1997;9:683-7. (Pubitemid 27315620)
12. Franceschi S, Panza E, La Vecchia C, et al. Nonspecific inflammatory bowel disease and smoking. Am J Epidemiol 1987;125:445-52. (Pubitemid 17024134)
13. Holdstock G, Savage D, Harman M, et al. Should patients with inflammatory bowel disease smoke? Br Med J (Clin Res Ed) 1984;288:362. (Pubitemid 14113678)
14. Jick H, Walker AM. Cigarette smoking and ulcerative colitis. N Engl J Med 1983;308:261-3. (Pubitemid 13174359)
15. Lakhan SE, Kirchgessner A. Antiinflammatory effects of nicotine in obesity and ulcerative colitis. J Transl Med 2011;9:1-10.
16. Lindberg E, Tysk C, Andersson K, et al. Smoking and inflammatory bowel disease. A case control study. Gut 1988;29:352-7. (Pubitemid 18082152)
17. Logan RF, Edmond M, Somerville KW, et al. Smoking and ulcerative colitis. Br Med J (Clin Res Ed). 1984;288:751-3. (Pubitemid 14117953)
18. Logan RF, Kay CR. Oral contraception, smoking and inflammatory bowel disease-findings in the Royal College of General Practitioners Oral Contraception Study. Int J Epidemiol 1989;18:105-7. (Pubitemid 19128640)
19. Lorusso D, Leo S, Misciagna G, et al. Cigarette smoking and ulcerative colitis. A case control study. Hepatogastroenterology 1989;36:202-4. (Pubitemid 19218613)
20. McGrath J, McDonald JW, MacDonald JK. Transdermal nicotine for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2004;18: CD004722.
21. Srivasta ED, Newcombe RG, Rhodes J. Smoking and ulcerative colitis: a community study. Int J Colorectal Dis 1993;8:71-4. (Pubitemid 23231016)
22. Thomas G A O, Rhodes J, Green JT, et al. Role of smoking in inflammatory bowel disease: implications for therapy. Postgrad Med J 2000;76:273-9. (Pubitemid 30223939)
23. Tobin MV, Logan RF, Langman MJ, et al. Cigarette smoking and inflammatory bowel disease. Gastroenterology 1987;93:316-21. (Pubitemid 17097599)
24. van der Heide F, Dijkstra A, Weersma RK, et al. Effects of active and passive smoking on disease course of crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2009;15:1199-207.
25. Samuelsson S. Ulceros Colit och Proktit [Dissertation]. Uppsala, Sweden: Department of Social Medicine, University of Uppsala, 1976.
26. Harries AD, Baird A, Rhodes J. Nonsmoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed) 1982;284:706.
27. Green JT, Rhodes J, Ragunath K, et al. Clinical status of ulcerative colitis in patients who smoke. Am J Gastroenterol 1998;93:1463-7. (Pubitemid 29075183)
28. Calabrese E, Yanai H, Shuster D, et al. Low-dose smoking resumption in exsmokers with refractory ulcerative colitis. J Crohns Colitis 2012;6:756-62.
29. Sandborn WJ. Nicotine therapy for ulcerative colitis: a review of rationale, mechanisms, pharmacology, and clinical results. Am J Gastroenterol 1999;94:1161-71.
30. Abraham N, Selby W, Lazarus R, et al. Is smoking an indirect risk factor for the development of ulcerative colitis? An age-and sex-matched case-control study. J Gastroenterol Hepatol 2003;18:139-46. (Pubitemid 36349858)
31. Motley RJ, Rhodes J, Ford GA, et al. Time relationships between cessation of smoking and onset of ulcerative colitis. Digestion 1987;37:125-7. (Pubitemid 17091832)
32. Motley RJ, Rhodes J, Kay S, et al. Late presentation of ulcerative colitis in exsmokers. Int J Colorectal Dis 1988;3:171-5.
33. Höie O, Wolters F, Riis L, et al. Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol 2007;102:1692-701. (Pubitemid 47206689)
34. Boyko EJ, Perera DR, Koepsell TD, et al. Effects of cigarette smoking on the clinical course of ulcerative colitis. Scand J Gastroenterol 1988;23:1147-52.
35. Odes HS, Fich A, Reif S, et al. Effects of current cigarette smoking on clinical course of Crohn's disease and ulcerative colitis. Dig Dis Sci 2001;46:1717-21. (Pubitemid 32727104)
36. Beaugerie L, Massot N, Carbonnel F, et al. Impact of cessation of smoking on the course of ulcerative colitis. Am J Gastroenterol 2001;96:2113-6. (Pubitemid 32660906)
37. Cosnes J. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol 2004;18:481-96. (Pubitemid 38667461)
38. Manguso F, Sanges M, Staiano T, et al. Cigarette smoking and appendectomy are risk factors for extraintestinal manifestations in ulcerative colitis. Am J Gastroenterol 2004;99:327-34. (Pubitemid 38279877)
39. Loftus EV Jr, Sandborn WJ, Tremaine WJ, et al. Primary sclerosing cholangitis is associated with nonsmoking; a casecontrol study. Gastroenterology 1996;110:1496-502. (Pubitemid 26134082)
40. Mitchell SA, Thyssen M, Orchard TR, et al. Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study. Gut 2002;51:567-73.
41. van Erpecum KJ, Smits SJ, van de Meeberg PC, et al. Risk of primary sclerosing cholangitis is associated with nonsmoking behavior. Gastroenterology 1996;110:1503-6. (Pubitemid 26134083)
42. Merrett MN, Mortensen N, Kettlewell M, et al. Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis. Gut 1996;38:362-4. (Pubitemid 26074315)
43. Joelsson M, Benoni C, Oresland T. Does smoking influence the risk of pouchitis following ileal pouch anal anastomosis for ulcerative colitis? Scand J Gastroenterol 2006;41:929-33. (Pubitemid 43995468)
44. Mahid SS, Minor KS, Stromberg AJ, et al. Active and passive smoking in childhood is related to the development of inflammatory bowel disease. Inflamm Bowel Dis 2007;13:431-8. (Pubitemid 46668248)
45. Persson PG, Ahlbom A, Hellers G. Inflammatory bowel disease and tobacco smoke-a case-control study. Gut 1990;31:1377-81.
46. Bridger S, Lee J C W, Bjarnason I, et al. In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis. Gut 2002;51:21-5. (Pubitemid 34717738)
47. Smith MB, Lashner BA, Hanauer SB. Smoking and inflammatory bowel disease in families. Am J Gastroenterol 1988;83:407-9.
48. Orholm M, Binder V, Sørensen TI, et al. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol 2000;35:1075-81.
49. Cosnes J, Carbonnel F, Beaugerie L, et al. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 1996;110:424-31. (Pubitemid 26043875)
50. Cosnes J, Carbonnel F, Carrat F, et al. Effects of current and former cigarette smoking on the clinical course of Crohn's disease. Aliment Pharmacol Ther 1999;13:1403-11. (Pubitemid 29516251)
51. Cottone M, Rosselli M, Orlando A, et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994;106:643-8. (Pubitemid 24064330)
52. Lindberg E, Jarnerot G, Huitfeldt B. Smoking in Crohn's disease: effect on localisation and clinical course. Gut 1992;33:779-82.
53. Russel MG, Volovics A, Schoon EJ, et al. Inflammatory bowel disease: is there any relation between smoking status and disease presentation? European Collaborative IBD Study Group. Inflamm Bowel Dis 1998;4:182-6. (Pubitemid 128699851)
54. Bustamante M, Nos P, Hoyos M, et al. Relationship between smoking and colonic involvement in inflammatory bowel disease. Rev Esp Enferm Dig 1998;90:833-40.
55. Karban A, Elliakim R. Effect of Smoking on inflammatory bowel diseases: is it disease or organ specific? World J Gastroenterol 2007;13:2150-2. (Pubitemid 46851147)
56. Eliakim R, Karmeli F, Cohen P, et al. Dual effect of chronic nicotine administration: augmentation of jejunitis and amelioration of colitis induced by iodoacetamide in rates. Int J Colorectal Dis 2001;16:14-21. (Pubitemid 32218972)
57. Eliakim R, Karmeli F. Divergent effects of nicotine administration on cytokine levels in rat small bowel mucosa, colonic mucosa, and blood. Isr Med Assoc J 2003;5:178-80. (Pubitemid 36469332)
58. Verschuere S, Bracke KR, Demoor T, et al. Cigarette smoking alters epithelial apoptosis and immune composition in murine GALT. Lab Invest 2011;91:1056-67.
59. Wang H, Zhao JX, Hu N, et al. Sidestream smoking reduces intestinal inflammation and increases expression of tight junction proteins. World J Gastroenterol 2012;18:2180-7.
60. Sugano N, Ito K. Nicotine switches the form of H2O2-induced cell death from apoptosis to necrosis in U937 cells. Immunol Lett 2000;72:163-6. (Pubitemid 30398589)
61. Crowley-Weber CL, Dvorakova K, Crowley C, et al. Nicotine increases oxidative stress, activates NF-kappaB and GRP78, induces apoptosis and sensitizes cells to genotoxic/xenobiotic stresses by a multiple stress inducer, deoxycholate: relevance to colon carcinogenesis. Chem Biol Interact 2003;145:53-66. (Pubitemid 36246610)
62. Takagi T, Naito Y, Mizushima K, et al. Inhalation of carbon monoxide ameliorates TNBS-induced colitis in mice through the inhibition of TNF-a expression. Dig Dis Sci 2010;55:2797-804.
63. Hegazi RA, Rao KN, Mayle A, et al. Carbon monoxide ameliorates chronic murine colitis througb a heme oxygenase 1-dependent pathway. J Exp Med 2005;202:1703-13. (Pubitemid 41815876)
64. Moore BA, Otterbein LE, Türler A, Choi AM, Bauer AJ. Inhaled carbon monoxide suppresses the development of postoperative ileus in the murine small intestine. Gastroenterology 2003;124:377-91. (Pubitemid 36169255)
65. Freitas A, Alves-Filho JC, Secco DD, et al. Heme oxygenase/carbon monoxide-biliverdin pathway down regulates neutrophil rolling, adhesion and migration in acute inflammation. Br J Pharmacol 2006;149:345-54. (Pubitemid 44582241)
66. + regulatory T cells. J Immunol 2005;174:5181-6. (Pubitemid 40593154)
67. Round JL, O'Connell RM, Mazmanian SK. Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmun 2010;34:J220-5.
68. Bergeron V, Grondin V, Rajca S, et al. Current smoking differentially affects blood mononuclear cells from patients with Crohn's disease and ulcerative colitis: relevance to its adverse role in the disease. Inflamm Bowel Dis 2012;18:1101-11.
69. Leong RW, Lawrance IC, Chow DK, et al. Association of intestinal granulomas with smoking, phenotype, and serology in Chinese patients with Crohn's disease. Am J Gastroenterol 2006;101:1024-9. (Pubitemid 43725316)
70. Aldhous MC, Prescott RJ, Roberts S, et al. Does nicotine influence cytokine profile and subsequent cell cycling/apoptotic responses in inflammatory bowel disease? Inflamm Bowel Dis. 2008;14:1469-82.
71. Prytz H, Benoni C, Tahesson C. Does smoking tighten the gut? Scand J Gastroenterol 1989;24:1084-8. (Pubitemid 19275593)
72. Suenaert P, Bulteel V, Den Hond E, et al. The effects of smoking and indomethacin on small intestinal permeability. Aliment Pharmacol Ther 2000;14:819-22. (Pubitemid 30352750)
73. Benomi C, PRytz H. Effects of smoking on the urine excretion of oral 51Cr-EDTA in UC. Gut 1998;42:656-8. (Pubitemid 28261051)
74. Richardson CE, Morgan JM, Jasani N, et al. Megacystis-microcolon- intestinal hypoperistalsis syndrome (MMIHS) is associated with absence of the alpha 3 nicotinic acetylcholine receptor subunit. Gastroenterology 2001;121:350-7. (Pubitemid 32729382)
75. Benjamin JL, Hedin CR, Koutsoumpas A, et al. Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. Inflamm Bowel Dis 2012;18:1092-100.
76. Hoentjen F, Tonkonogy SL, Qian BF, et al. CD4 (+) T lymphocytes mediate colitis in HLA-B27 transgenic rats mono-associated with non-pathogenic Bacteroides vulgatus. Inflamm Bowel Dis 2007;13:317-24. (Pubitemid 46465913)
77. Pullan RD, Rhodes J, Ganesh S, et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med 1994;330:811-5. (Pubitemid 24083559)
78. Sandborn WJ, Tremaine WJ, Offord KP, et al. Transdermal nicotine for mildly to moderately active ulcerative colitis. Ann Intern Med 1997;126:364-71.
79. Thomas GA, Rhodes J, Mani V, et al. Transdermal nicotine as maintenance therapy for ulcerative colitis. N Engl J Med 1995;332:988-92.
80. Guslandi M, Tittobello A. Outcome of ulcerative colitis after treatment with transdermal nicotine. Eur J Gastroenterol Hepatol 1998;10:513-5. (Pubitemid 28306546)
81. Guslandi M. Long-term effects of a single course of nicotine treatment in acute ulcerative colitis: remission maintenance in a 12-month follow-up study. Int J Colorectal Dis 1999;14:261-2. (Pubitemid 30000277)
82. Thomas GA, Rhodes J, Ragunath K, et al. Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis. Eur J Gastroenterol Hepatol 1996;8:769-76. (Pubitemid 26275696)
83. Guslandi M, Frego R, Viale E, et al. Distal ulcerative colitis refractory to rectal mesalamine: role of transdermal nicotine versus oral mesalamine. Can J Gastroenterol 2002;16:293-6. (Pubitemid 34846664)
84. Sandborn WJ, Tremaine WJ, Leighton JA, et al. Nicotine tartrate liquid enemas for mildly to moderately active left-sided ulcerative colitis unresponsive to firstline therapy: a pilot study. Aliment Pharmacol Ther 1997;11:663-71. (Pubitemid 27376352)
85. Ingram JR, Thomas G A O, Rhodes J, et al. A randomized trial of nicotine enemas for active ulcerative colitis. Clin Gastroenterol Hepatol 2005;3:1107-14. (Pubitemid 41565377)
86. Thomas GA, Davies SV, Rhodes J, et al. Is transdermal nicotine associated with cardiovascular risk? J R Coll Physicians Lond 1995;29:392-6.
87. Ingram JR, Rhodes J, Collins PW, et al. Plasma fibrinogen in ulcerative colitis: the effect of disease activity and nicotine therapy in a randomised controlled trial. Dig Liver Dis 2005;37:832-7. (Pubitemid 44356114)